
Clinically validated for
HR+, HER2-, N0/N1, early-stage breast cancer patients
HR+, HER2-, N0/N1, early-stage breast cancer patients
The Patient Profile Navigator will provide you with N0 and N1 clinical data to help you decide whether an Oncotype DX® test would aid in making these important decisions.
With some clicks you can:
- Choose your clinical pathological parameter/s of interest
- Browse through clinical data
- Get in contact with an Exact Sciences representative

The clarity your patients deserve
Moving from assumed to proven chemotherapy benefit.
In your clinical practice you need to make important decisions and need to consider complex questions daily for your patients: Will my patient really benefit from chemotherapy? What is the outcome for my patient in the next 5-9 years? Should I order an Oncotype DX Breast Recurrence Score® test to better understand the underlying tumour biology of my patient’s cancer and thus be able to make a tailored chemotherapy treatment decision?
Get in touch
Have questions about Oncotype DX®?
